Ultragenyx Pharmaceutical saw the highest growth of 3.99% in patent filings in June and 1.49% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.66% and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Ultragenyx Pharmaceutical‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Ultragenyx Pharmaceutical has been focused on protecting inventions in European Patent Office(EPO) with four publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings with nearly 43% of filings. The European Patent Office(EPO), United States(US), Australia(AU), and Spain(ES) patent Office are among the top ten patent offices where Ultragenyx Pharmaceutical is filings its patents. Among the top granted patent authorities, Ultragenyx Pharmaceutical has 33% of its grants in United States(US), 33% in Spain(ES) and 17% in Croatia(HR).
University of Pennsylvania could be the strongest competitor for Ultragenyx Pharmaceutical
Patents related to rare diseases and cell & gene therapy lead Ultragenyx Pharmaceutical's portfolio
Ultragenyx Pharmaceutical has the highest number of patents in rare diseases followed by, cell & gene therapy and genomics. For rare diseases, nearly 100% of patents were filed and 33% of patents were granted in Q2 2024.
Osteogenesis imperfecta related patents lead Ultragenyx Pharmaceutical portfolio followed by wilson disease, and polycystic kidney disease
Ultragenyx Pharmaceutical has highest number of patents in osteogenesis imperfecta followed by wilson disease, polycystic kidney disease, metabolic acidosis, and osteomalacia.
For comprehensive analysis of Ultragenyx Pharmaceutical's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
